We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

109 hedge funds and large institutions have $500M invested in Taro Pharmaceutical Industries Ltd. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 45 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $336K | Put options by funds: $255K

13% more capital invested

Capital invested by funds: $442M → $500M (+$58M)

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

0% more funds holding

Funds holding: 109 → 109 (0)

40% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 45

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
109
Holders Change
–
Holders Change %
0%
% of All Funds
2.5%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
14
Increased
27
Reduced
45
Closed
13
Calls
$336K
Puts
$255K
Net Calls
+$81K
Net Calls Change
+$108K

Top Buyers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$20.3M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$15M
3
Robeco Institutional Asset Management
Robeco Institutional Asset Management
Netherlands
+$3.64M
4
Morgan Stanley
Morgan Stanley
New York
+$3.45M
5
Northern Trust
Northern Trust
Illinois
+$3.21M

Top Sellers

1
MICM
Matthews International Capital Management
California
-$27.3M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$25.7M
3
Millennium Management
Millennium Management
New York
-$5.43M
4
LP
LMR Partners
United Kingdom
-$3.25M
5
FCH
Freestone Capital Holdings
Washington
-$2.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
JAM
26
Jupiter Asset Management
United Kingdom
$4.71M – – –
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$4.26M +$287K +2,611 +8%
Robeco Institutional Asset Management
28
Robeco Institutional Asset Management
Netherlands
$3.84M +$3.64M +33,170 New
AIIMS
29
Analyst IMS Investment Management Services
Israel
$3.62M – – –
Canada Pension Plan Investment Board
30
Canada Pension Plan Investment Board
Ontario, Canada
$3.58M -$1.14M -10,377 -25%
SCP
31
Seizert Capital Partners
Michigan
$3.4M – – –
Goldman Sachs
32
Goldman Sachs
New York
$3.22M -$577K -5,256 -16%
MWNA
33
Marshall Wace North America
New York
$2.85M +$2.47M +22,460 +1,037%
Schroder Investment Management Group
34
Schroder Investment Management Group
United Kingdom
$2.81M -$25.7M -233,504 -91%
Russell Investments Group
35
Russell Investments Group
United Kingdom
$2.76M -$91.5K -833 -3%
Boston Partners
36
Boston Partners
Massachusetts
$2.72M +$2.59M +23,541 New
OAM
37
Oxford Asset Management
United Kingdom
$2.51M +$536K +4,878 +29%
JP Morgan Chase
38
JP Morgan Chase
New York
$2.48M -$2.34M -21,312 -50%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$2.33M +$933K +8,492 +73%
AG
40
Aperio Group
California
$2.23M -$742K -6,757 -26%
EF
41
Empirical Finance
Pennsylvania
$1.59M +$468K +4,263 +45%
Connor, Clark & Lunn Investment Management (CC&L)
42
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.48M +$1.4M +12,750 New
SFM
43
Systematic Financial Management
New Jersey
$1.37M -$243K -2,215 -16%
Charles Schwab
44
Charles Schwab
California
$1.16M +$226K +2,054 +26%
HCM
45
Hudson Capital Management
New Jersey
$1.07M +$136K +1,235 +15%
SEI Investments
46
SEI Investments
Pennsylvania
$1.03M -$572K -5,206 -37%
ACA
47
Anchor Capital Advisors
Massachusetts
$944K -$149K -1,359 -14%
Barclays
48
Barclays
United Kingdom
$891K -$483K -4,401 -36%
Creative Planning
49
Creative Planning
Kansas
$825K – – –
AIM
50
Assured Investment Management
New York
$815K -$576K -5,248 -43%
1
2
3 4 5

TARO Hedge Fund Activity: Q2 2018 in Review

109 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2018, worth a combined $500M — up 13% from $442M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TARO positions and 13 closed out — a net gain of 1 holder — while 27 added to existing stakes and 45 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $20.3M. The largest seller was Matthews International Capital Management, cutting an estimated $27.3M.

  • 109 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $500M of Taro Pharmaceutical Industries Ltd. stock for Q2 2018, up 13% quarter-over-quarter.
  • 14 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2018 and 13 closed out, a net change of +1 holder.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2018 was Arrowstreet Capital, an estimated $20.3M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2018 was Matthews International Capital Management, an estimated $27.3M sold.

Based on aggregated 13F filings for Q2 2018.